Agenus | AGEN - سرمایه عادی





سرمایه عادی تغییر دادن تاریخ
AbbVie USD 1.77B 1.75B 2025-06
Agenus USD 35.32M 2.51M 2025-12
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Celldex Therapeutics USD 66.55M 102K 2025-12
CSL USD 482.13M 93.87M 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.08B 49.43M 2025-12
Incyte USD 198.46M 2.33M 2025-12
Intrexon USD 0 0 2024-06
J&J USD 2.41B 584K 2025-09
Jiangsu Hengrui CNY 6.64B 0 2025-09
Karyopharm Therapeutics USD 13K 0 2024-09
MacroGenics USD 63.32M 60K 2025-12
Merck EUR 434.78M 0 2025-12
Merck USD 2.49B 15.79M 2025-09
Northwest Biotherapeutics USD 1.14M 30K 2023-09
Novartis USD 1.91B 10.64M 2025-12
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Rigel Pharmaceuticals USD 17K 158K 2024-06
Veracyte USD 79.05M 377K 2025-12